IUHSA
SNDX icon

Itau Unibanco Holding S.A.’s Syndax Pharmaceuticals SNDX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,423
Closed -$13K – 966
2019
Q3 		$13K Buy
+1,423
New +$13K ﹤0.01% 275

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Itau Unibanco Holding S.A.'s SNDX Position: Q3 2019 in Review

Itau Unibanco Holding S.A. sold out of Syndax Pharmaceuticals (SNDX) in Q3 2019, closing a stake of 1,423 shares — an estimated $13K sold.

Itau Unibanco Holding S.A. first reported a position in SNDX in Q1 2017 and held it in 10 quarters. The position peaked at $47K in Q1 2018. 72 funds tracked by Wall St. Rank hold SNDX as of Q3 2019.

  • Itau Unibanco Holding S.A. reported no remaining Syndax Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,423 Syndax Pharmaceuticals shares in Q3 2019, an estimated $13K.
  • Itau Unibanco Holding S.A. first reported a position in Syndax Pharmaceuticals in Q1 2017 and held it in 10 quarters.
  • Itau Unibanco Holding S.A.'s Syndax Pharmaceuticals position peaked at $47K in Q1 2018.
  • 72 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2019, filed 14 Nov 2019.